Estimating the potential contribution of stroke treatments and preventative policies to reduce the stroke and ischemic heart disease mortality in Turkey up to 2032: a modelling study

Table 1 Scenarios for the uptake rates of medical therapies in Turkish population

	Baseline scenario (uptake rates in 2012)	Conservative scenario targets	Feasible scenario targets	Optimal scenario targets
Acute stroke treatment
Thrombolysis	0,01	0,011	0,05	0,13
Aspirin	0,50	0,55	0,70	0,85
Stroke unit	0,00	0,01	0,40	0,85
Secondary prevention
Aspirin	0,26	0,29	0,50	0,81
Statin	0,48	0,53	0,70	0,80^a
Warfarin	0,14	0,20	0,40	0,50^a
BP control	0,35	0,39	0,50	0,62
Smoking cessation	0,30	0,33	0,50	0,60^a
Primary prevention
BP control	0,07	0,08	0,10	0,12^a
HbA1c control	0,49	0,54	0,70	0,80^a
Smoking cessation	0,04	0,07	0,10	0,13
Warfarin	0,30	0,33	0,50	0,78

ISSN: 1471-2458